Paroxysmal Nocturnal Hemoglobinuria (PNH)

Palliative Care - 2024 Los Angeles Patient and Family Conference Session

Topic(s)

Living Well with Bone Marrow Failure

Managing Your Treatment

Presenter(s)

Finly Zachariah, MD

Finly Zachariah explains how and why treating pain issues during treatment can be beneficial to patients in this session from the 2024 Los Angeles Patient and Family Conference Session.

Supportive Care Management - 2024 Los Angeles Patient and Family Conference

Thumbnail for video Watch Now

Topic(s)

Managing Your Treatment

Presenter(s)

Erin Kopp, DNP

Erin Kopp explains strategies for dealing with pain and other issues for patients with bone marrow failure diseases in this session from the 2024 Los Angeles Patient and Family Conference.

Inherited Bone Marrow Failure Syndromes - 2024 Los Angeles Patient and Family Conference

Thumbnail for video Watch Now

Topic(s)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Aplastic Anemia

Myelodysplastic Syndromes (MDS)

Presenter(s)

Paibel Aguayo-Hiraldo, MD

Dr. Paibel Aguayo-Hiraldo, MD, anticipates your questions about inherited bone marrow failure syndromes in this recording from the 2024 Los Angeles Patient and Family Conference.

Advances in the Therapy of PNH - 2024 Los Angeles Patient and Family Conference

Thumbnail for video Watch Now

Topic(s)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Presenter(s)

Vinod Pullarkat, MD, MRCP

Dr. Vinod Pullarkat explains how the treatments and therapies for PNH, or Paroxysmal Nocturnal Hemoglobinuria, have changed and which new therapies may be available soon.

Cardiovascular Concerns after HCT from the 2024 Los Angeles Patient and Family Conference

Thumbnail for video Watch Now

Topic(s)

Bone Marrow Transplant

Presenter(s)

June-Wha Rhee, MD

Dr. June-Wha Rhee describes the potential for cardiovascular complications after HCT, or hematopoietic stem cell transplantation, in this session from the 2024 Los Angeles Patient and Family Conference.

ASH 2023 Update - Aplastic Anemia and PNH

Thumbnail for video Watch Now

Topic(s)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Aplastic Anemia

Presenter(s)

David Dingli, M.D., Ph.D.

In this webinar, Dr. David Dingli presents the latest research presented the American Society of Hematology meeting on Aplastic Anemia and PNH. This is an advanced presentation.

Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria

Read more about Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria

Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria

Read more about Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria

Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape

Read more about Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape

Paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal hemoglobinuria: (pa

Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria

Read more about Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria

Background: Persistent hemolytic anemia hemolytic anemia: Anemia due primarily to the excessive hemolysis or destruction of red blood cells

Subscribe to Paroxysmal Nocturnal Hemoglobinuria (PNH)

NFL Player Teams Up with AAMDSIF

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Palliative Care - 2024 Los Angeles Patient and Family Conference Session

Supportive Care Management - 2024 Los Angeles Patient and Family Conference

Inherited Bone Marrow Failure Syndromes - 2024 Los Angeles Patient and Family Conference

Advances in the Therapy of PNH - 2024 Los Angeles Patient and Family Conference

Cardiovascular Concerns after HCT from the 2024 Los Angeles Patient and Family Conference

ASH 2023 Update - Aplastic Anemia and PNH

Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria

Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria

Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape

Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria

Website Feedback